SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+77.25%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.36B
AUM Growth
+$1.36B
(+29%)
Cap. Flow
-$52.8M
Cap. Flow
% of AUM
-3.89%
Top 10 Holdings %
Top 10 Hldgs %
67.88%
Holding
77
New
7
Increased
14
Reduced
17
Closed
16
Top Buys
| 1 |
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
|
$40.6M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$30.2M |
| 3 |
Merck
MRK
|
$21.9M |
| 4 |
Biogen
BIIB
|
$18.9M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$18.8M |
Top Sells
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$46.7M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$26.2M |
| 3 |
Bristol-Myers Squibb
BMY
|
$24.3M |
| 4 |
AGN
Allergan plc
AGN
|
$22.6M |
| 5 |
Amgen
AMGN
|
$17.9M |
Sector Composition
| 1 | Healthcare | 96.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDMN
26
DELISTED
Kadmon Holdings, Inc.
KDMN
| $10.7M | 0.77% | 2,368,958 -240,800 | -9% | -$1.09M |
|
27
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $10.2M | 0.74% | 922,700 | – | – |
|
28
TG Therapeutics
TGTX
$4.65B
| $9.01M | 0.65% | 811,292 -922,336 | -53% | -$10.2M |
|
|
CALA
29
DELISTED
Calithera Biosciences, Inc
CALA
| $8.33M | 0.6% | 1,458,821 +493,969 | +51% | +$2.82M |
|
|
DERM
30
DELISTED
Dermira, Inc.
DERM
| $8.27M | 0.6% | 545,466 -444,702 | -45% | -$6.74M |
|
|
CHMA
31
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $8.09M | 0.58% | 1,630,221 | – | – |
|
|
XLRN
32
DELISTED
Acceleron Pharma Inc.
XLRN
| $7.8M | 0.56% | 147,032 -261,230 | -64% | -$13.9M |
|
33
Iterum Therapeutics
ITRM
$30.2M
| $7.77M | 0.56% | 1,726,514 | – | – |
|
|
ARQL
34
DELISTED
Arqule Inc
ARQL
| $7.73M | 0.56% | 387,469 -5,918 | -2% | -$118K |
|
35
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.42M | 0.53% | 2,151,164 +1,634,430 | +316% | +$5.64M |
|
|
ETTX
36
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $5.87M | 0.42% | 1,180,178 | – | – |
|
|
OTIC
37
DELISTED
Otonomy, Inc.
OTIC
| $5.8M | 0.42% | 1,515,629 +77,664 | +5% | +$297K |
|
|
SGEN
38
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.71M | 0.41% | +50,000 | New | +$5.71M |
|
|
FTSV
39
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $5.46M | 0.39% | 138,643 -380,655 | -73% | -$15M |
|
40
Zymeworks
ZYME
$1.12B
| $4.89M | 0.35% | 107,552 -80,886 | -43% | -$3.68M |
|
41
Amicus Therapeutics
FOLD
$2.34B
| $4.63M | 0.33% | 475,330 -247,644 | -34% | -$2.41M |
|
42
XBiotech
XBIT
$96.3M
| $4.5M | 0.32% | 240,995 -117,668 | -33% | -$2.2M |
|
|
ORTX
43
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $3.9M | 0.28% | 283,406 | – | – |
|
|
FOMX
44
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.87M | 0.28% | 1,162,176 -37,078 | -3% | -$123K |
|
45
Applied Therapeutics
APLT
$71M
| $3.68M | 0.27% | 134,825 -7,179 | -5% | -$196K |
|
46
Aclaris Therapeutics
ACRS
$209M
| $3.61M | 0.26% | 1,911,573 | – | – |
|
|
DRNA
47
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.51M | 0.25% | 159,512 -183,243 | -53% | -$4.04M |
|
48
KALA BIO
KALA
$78.8M
| $2.45M | 0.18% | 664,641 +186,435 | +39% | +$688K |
|
49
Apellis Pharmaceuticals
APLS
$3.48B
| $1.52M | 0.11% | 49,580 | – | – |
|
50
Synlogic
SYBX
$17M
| $1.48M | 0.11% | 574,972 | – | – |
|